KINGSTON, Jamaica  —  The Jamaica Customs Agency (JCA) is reporting an emerging synthetic drug threat within Jamaica’s border environment, with an increase in MDMA/ecstasy detections between January 2024 up to June 5, 2026.

In a statement on Wednesday, the agency said during the period under review, the JCA detected a cumulative total of 34,292 Ecstasy/MDMA tablets and pills.

Noting that while the number of detections remains relatively low when compared to traditional narcotics such as cocaine and marijuana, customs highlighted that the quantity of tablets per shipment and the emergence of recurring detections indicate the diversification of transnational criminal activity and the growing exposure of Jamaica to international synthetic drug supply chains.